A Study of the Safety and Efficacy of Venetoclax for Participants With Chronic Lymphocytic Leukemia (CLL) Used in Routine Clinical Practice

  • End date
    Sep 30, 2025
  • participants needed
  • sponsor
Updated on 8 April 2021
chronic lymphocytic leukemia


This observational study will evaluate the safety and effectiveness of Venetoclax used in routine clinical practice for participants diagnosed with chronic lymphocytic leukemia (CLL).

Condition Cancer, Chronic Lymphocytic Leukemia, Lymphocytic Leukemia, Chronic, Cancer/Tumors, Ewing's Family Tumors, Cancer (Pediatric), Neoplasms, Cancer, Chronic Lymphocytic Leukemia (CLL), Cancer, Chronic Lymphocytic Leukemia (CLL), Cancer, Chronic Lymphocytic Leukemia (CLL), Cancer, Chronic Lymphocytic Leukemia (CLL), Cancer, Chronic Lymphocytic Leukemia (CLL), Cancer, Chronic Lymphocytic Leukemia (CLL), Cancer, Chronic Lymphocytic Leukemia (CLL)
Clinical Study IdentifierNCT04178317
Last Modified on8 April 2021


Yes No Not Sure

Inclusion Criteria

Participants diagnosed with chronic lymphocytic leukemia who have been prescribed Venetoclax for the first time according to the approved label
Participants (and/or legal representative) who voluntarily agree to participate in this study and sign informed consent

Exclusion Criteria

Participants with contraindications to venetoclax as listed on the approved local label
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note